Robert S. Fishman, Chief Medical Officer at CORCEPT THERAPEUTICS INC (CORT), sold 8,000 shares at $16.72 ($134K) on 2017-12-08, disclosed to the SEC on 2017-12-12.
Open-market sale of $134k CORT by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| CORT | SELL | 2018-09-11 | $117K | — | Filing → |
| CORT | SELL | 2018-08-08 | $113K | — | Filing → |
| CORT | SELL | 2018-07-09 | $121K | — | Filing → |